|
Treatment Agent, n (%)
|
| Rituximab |
201 (33.6) |
78 (43.3) |
16 (31.4) |
6 (28.6) |
2 (20.0) |
| R-CHOP |
143 (24.0) |
11 (6.1) |
4 (7.8) |
2 (9.5) |
|
| BR |
143 (24.0) |
41 (22.8) |
9 (17.8) |
1 (4.8) |
2 (20.0) |
| R-CVP |
71 (11.9) |
12 (6.7) |
2 (3.9) |
1 (4.8) |
|
| FCR |
10 (1.7) |
2 (1.1) |
1 (2.0) |
1 (4.8) |
|
| Cyclophosphamide plus Rituximab |
6 (1.0) |
13 (7.2) |
6 (11.8) |
|
|
| Fludarabine plus Rituximab |
5 (0.8) |
1 (0.6) |
|
|
|
| Chlorambucil |
3 (0.5) |
1 (0.6) |
1(2.0) |
|
|
| Lenalidomide |
3 (0.5) |
2 (1.1) |
|
2 (9.5) |
3(30.0) |
| Cyclophosphamide |
1 (0.2) |
2 (1.1) |
2 (3.9) |
|
|
| Fludarabine |
1 (0.2) |
4 (2.2) |
|
1(4.8) |
|
| Lenalidomide plus Rituximab |
1 (0.2) |
|
1 (2.0) |
3(14.3) |
1 (10.0) |
| Rituximab plus Transplant |
1 (0.2) |
5 (2.8) |
|
|
|
| Othera |
9 (1.5) |
10 (5.6) |
9 (17.6) |
4 (19.1) |
2(20.0) |
| Total |
598 (100) |
180 (100) |
51 (100) |
21 (100) |
10 (100) |